592 results on '"Hershberger, Ray E."'
Search Results
52. Communal Coping as a Strategy to Enhance Family Engagement in Dilated Cardiomyopathy
53. Dilated Cardiomyopathy
54. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The Dilated Cardiomyopathy Precision Medicine Study
55. Phenotypic And Genetic Profile Of Scn5a Variants In Idiopathic Dilated Cardiomyopathy
56. Validating an Idiopathic Dilated Cardiomyopathy Diagnosis Using Cardiovascular Magnetic Resonance: The DCM Precision Medicine Study
57. 52 - The Dilated, Restrictive, and Infiltrative Cardiomyopathies
58. Functional Characterization of TNNC1 Rare Variants Identified in Dilated Cardiomyopathy
59. HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
60. Rare variant mutations identified in pediatric patients with dilated cardiomyopathy
61. Genome-wide Studies of Copy Number Variation and Exome Sequencing Identify Rare Variants in BAG3 as a Cause of Dilated Cardiomyopathy
62. Response to McGurk et al
63. Beta-Adrenergic Receptor Agonists and Antagonists in Heart Failure
64. Colaboradores
65. 52 - Miocardiopatías dilatada, restrictiva e infiltrante
66. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals
67. The Evolving Science of Dilated Cardiomyopathy
68. Effectiveness of the Family Heart TalkCommunication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial
69. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia
70. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain
71. Genetic Evaluation of Dilated Cardiomyopathy
72. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death
73. An International Evidence Based Reappraisal of Genes Associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) using the ClinGen Framework
74. International Evidence Based Reappraisal of Genes Associated with Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
75. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
76. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy
77. Cardiovascular Genetic Medicine: Evolving Concepts, Rationale, and Implementation
78. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
79. The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy
80. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure)
81. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure
82. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy
83. The use of positive inotropes in end-of-life heart failure care
84. Variant Interpretation for Dilated Cardiomyopathy (DCM): Refinement of the ACMG/ClinGen Guidelines for the DCM Precision Medicine Study
85. Beta-blocker use in decompensated heart failure
86. Mutations of presenilin genes in dilated cardiomyopathy and heart failure
87. Daclizumab to prevent rejection after cardiac transplantation
88. Dilated cardiomyopathy: the complexity of a diverse genetic architecture
89. Mutations of Presenilin Genes in Dilated Cardiomyopathy and Heart Failure
90. Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy
91. Clinical Characteristics of 304 Kindreds Evaluated for Familial Dilated Cardiomyopathy
92. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation
93. Correction: Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics(ACMG)
94. 77 - The Dilated, Restrictive, and Infiltrative Cardiomyopathies
95. An Evidence-based Assessment of Genes in Dilated Cardiomyopathy
96. Considering complexity in the genetic evaluation of dilated cardiomyopathy
97. Attitudes of Dilated Cardiomyopathy Patients and Investigators Toward Genomic Study Enrollment, Consent Process, and Return of Genetic Results
98. Novel heterozygous truncating titin variants affecting the A‐band are associated with cardiomyopathy and myopathy/muscular dystrophy
99. SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy
100. Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.